Editor's Note The US Food and Drug Administration (FDA) has deemed the recall of Sentec Percussionaire’s Phasitron 5 In-Line Valve—a component of the manufacturer’s Intrapulmonary Percussive Ventilation (IPV) therapy system—a Class 1, the most severe category indicating serious risk of injury or death.   According to the agency’s October 2…

Read More

Editor's Note The US Food and Drug Administration (FDA) designated software-related recalls for Fresenius Kabi USA’s Iveni Infusion Systems and Philips Respironics Triology Evo ventilators as class 1, the most severe category indicating serious risk of injury or death. According to FDA’s October 1 announcement, Fresenius recalled the Ivenix Infusion…

Read More

Editor's Note Although data suggest transcatheter edge-to-edge repair (TEER) using the MitraClip device may offer similar outcomes to mitral valve surgery in patients with heart failure and functional mitral regurgitation (FMR), experts have criticized the research, TCT MD reported September 1. Presented at the recent European Society of Cardiology (ESC)…

Read More

Editor's Note Research shows antibiotic-resistant infections could lead to 8.2 million deaths annually by 2050, representing a 75% increase from current rates, according to a September 17 article in HealthDay. Published in the Lancet, the new study highlights the growing threat of growing threat of antimicrobial resistance (AMR), predicting that…

Read More

Editor's Note An American Hospital Association (AHA) analysis of data from Vizient reveals that hospital performance levels in the first quarter of this year was on par with performance prior to the COVID-19 pandemic, despite patients exhibiting more significant healthcare needs. Released this month, the report analyzes data from 2019…

Read More

Editor's Note The US Food and Drug Administration (FDA) has designated Fresenius Kabi’s recall of certain Ivenix infusion system components as Class 1, the most severe category indicating risk of serious injury or death. According to the agency’s September 16 announcement, the recalled items consist of a certain lot (3010538)…

Read More

Editor's Note A recent study in JAMA Surgery showed women with hepatocellular carcinoma (HCC) were 8% less likely than men to receive a liver transplant and 6% more likely to die or be removed from the waitlist, Healio reported September 9.    The study, which analyzed 31,725 adults waitlisted for…

Read More

Editor's Note Recalls of certain devices and instruction updates for others prompted the US Food and Drug Administration (FDA) to issue Class 1 recalls—the most severe category indicating risk of serious injury or death—for two groups of products: Medtronic’s McGrath MAC and MAC EMS Video Laryngoscopes and Breas Medical’s Vivo…

Read More

Editor's Note A recent study conducted across 185 hospital wards in England highlights the significant impact of nurse staffing levels and staff composition on patient mortality. Published August 19 in JAMA, the study analyzed data from over 626,000 hospital admissions between 2015 and 2020. It found that low staffing levels…

Read More

Editor's Note A post hoc analysis of the SCOT phase 3 randomized clinical trial reveals that initiating adjuvant chemotherapy more than 6 weeks after surgery is linked to worse disease-free survival (DFS) in patients with high-risk stage II and stage III colorectal cancer. Published June 12 in JAMA Surgery, the…

Read More